SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Dr. Lal PathLabs gets nod to acquire 70% stake in DLPLB

07 Aug 2017 Evaluate

Dr. Lal PathLabs has received an approval to acquire to 70 per cent stake in Dr. Lal Path Labs Bangladesh (DLPLB) from its existing shareholders, with the objective of strengthening its presence in Bangladesh. Prior to the company’s investment, DLPLB shall be acquiring the running diagnostics business of a sole-proprietorship firm in Dhaka, Bangladesh.

The Board of Directors of the Company at their meeting held on August 07, 2017, has given the approval for the same.

Dr. Lal PathLabs is a provider of diagnostic and related healthcare tests and services in India. Through its integrated, nationwide network, the company offers patients and healthcare providers a broad range of diagnostic and related healthcare tests and services for use in core testing, patient diagnosis and the prevention, monitoring and treatment of disease and other health conditions.

Dr. Lal Pathlabs Share Price

1403.15 -8.60 (-0.61%)
17-Apr-2026 16:59 View Price Chart
Peers

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×